Basic Information
Elixir Medical is committed to transforming the care of patients with heart and vascular diseases through innovation.Since 2005, the company has been dedicated to improving the treatment of vascular diseases in the following areas: Drug-Eluting Coronary Stent Systems (DES);Fully bioresorbable drug-eluting stent systems (BRS); Drug-eluting coronary bioadaptor systems.Its latest innovation, the DynamX™ Coronary Bioadaptor System, aims to achieve significant advancements beyond drug-eluting stents (DES).
Elixir Medical Corporation
Palmdale,California,United States of America
51~100 people
January 01, 2004
--
